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Background: Vaginal epithelial cells (VECs) produce antimicrobial peptides including human β-defensin 2 (hBD2)
and secretory leukocyte protease inhibitor (SLPI), as well as cytokines and chemokines that play vital roles in mucosal
innate immunity of the female reproductive tract. Houttuynia cordata Thunb (H. cordata), a herbal plant found in Asia,
possesses various activities including antimicrobial activity and anti-inflammation. As inflammation and infection are
commonly found in female reproductive tract, we aimed to investigate the effects of H. cordata water extract in
modulating innate immune factors produced by VECs.
Methods: Primary human VECs were cultured and treated with H. cordata at a concentration ranging from 25–200
μg/ml for 6 or 18 h. After treatment, the cells and culture supernatants were harvested. The expression of hBD2 and
SLPI mRNA was evaluated by quantitative real-time reverse transcription PCR. Levels of secreted hBD2 and SLPI as well
as cytokines and chemokines in the supernatants were measured by ELISA and Luminex assay, respectively. Cytotoxicity
of the extract on VECs was assessed by CellTiter-Blue Cell Viability Assay.
Results: H. cordata did not cause measurable toxicity on VECs after exposure for 18 h. The expression of hBD2 and SLPI
mRNA as well as the secreted hBD2 protein were increased in response to H. cordata exposure for 18 h when
compared to the untreated controls. However, treatment with the extract for 6 h had only slight effects on the
mRNA expression of hBD2 and SLPI. The secretion of IL-2 and IL-6 proteins by VECs was also increased, while the
secretion of CCL5 was decreased after treatment with the extract for 18 h. Treatment with H. cordata extract had
some effects on the secretion of IL-4, IL-8, CCL2, and TNF-α, but not statistically significant.
Conclusions: H. cordata water extract modulates the expression of antimicrobial peptides and cytokines produced by
VECs, which play an important role in the mucosal innate immunity in the female reproductive tract. Our findings
suggest that H. cordata may have immunomodulatory effects on the vaginal mucosa. Further studies should be
performed in vivo to determine if it can enhance mucosal immune defenses against microbial pathogens.
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The lower female reproductive tract is the site of entry
for several pathogens including bacteria, yeasts, and vi-
ruses that may cause sexually transmitted infections [1,
2]. The immune system of mucosal surfaces functions as
the first line of host defense against pathogen invasion to* Correspondence: wipawee.ni@psu.ac.th
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creativecommons.org/publicdomain/zero/1.0/protect underlying tissues and organs [1, 3]. The vaginal
epithelium plays an important role in the innate immunity
of the female reproductive tract, by providing a physical
barrier and producing antimicrobial peptides, such as hu-
man β-defensin 2 (hBD2) and secretory leukocyte protease
inhibitor (SLPI), and other innate immune mediators, in
particular cytokines and chemokines [2, 4–6]. These im-
mune mediators possess potent antimicrobial activities
against a broad range of infectious pathogens, including
human immunodeficiency virus type 1 (HIV-1) andss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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mune responses and homeostasis [7–14].
Previous studies revealed that hBD2 and SLPI can in-
hibit HIV-1 infection [7, 10, 15, 16]. However, the secre-
tion of hBD2 and SLPI in cervicovaginal lavages may
fluctuate during a menstrual cycle [2]. In addition, levels
of SLPI protein have been shown to be decreased in the
cervicovaginal secretions of post-menopausal women [17].
These may lead to impairment of the immune responses
and make those women become susceptible to immune-
mediated vaginal infections. Thus, the induction of these
immune mediators may help in maintaining mucosal im-
munity and preventing microbial invasion.
Some of these immune mediators are constitutively pro-
duced by vaginal epithelial cells (VECs). They can also be
up-regulated by different microbial components and cyto-
kines [4, 5, 18]. Previous studies reported that the produc-
tion of hBD2 and SLPI by epithelial cells was induced by
various microbes, microbial compounds, and cytokines
[18–22]. Moreover, levels of cytokine and chemokine pro-
duction were increased in response to different microor-
ganisms and other cytokines [4, 5, 12, 18]. It is not known,
however, if the expression of these innate immune media-
tors can be up-regulated by herbal plant extracts.
Houttuynia cordata Thunb (H. cordata), a herbal plant
found in Asian countries, has long been in medical and
dietary use by local people in this region [23]. It has
antimicrobial activity against several bacteria and viruses
[23–26], and also possesses other activities including anti-
allergic [27], anti-inflammatory [28], antioxidative [29],
and anticancer effects [30, 31]. Most laboratory studies
have focused on the modulation of antimicrobial peptides
and innate immune mediators by microbial components
[18–21], but the role of herbal plant extracts on mucosal
innate immunity is not well established. Therefore, the
goal of this study was to evaluate the effects of H. cordata
extract on the expression of hBD2 and SLPI as well as
various cytokines and chemokines produced by human
VECs. We demonstrated that H. cordata water extract in-
duced the expression of hBD2 and SLPI mRNA in human
VEC culture without measurable cytotoxicity. The secre-
tion of hBD2 protein and the levels of IL-2 and IL-6 in the
cell culture supernatants were also significantly increased
in the presence of the extract.
Methods
Compound and reagent
Pure powdered extract of H. cordata was ordered from Erica
Botanical Products (Xi’an, China). It was certified as free of
bacterial or fungal contamination. The stock solution was
prepared in sterile water. Tumor necrosis factor-alpha (TNF-
α) used as a positive control for the induction of hBD2 and
SLPI was ordered from PeproTech (Rocky Hill, CT, USA).Fibroblast cell culture
The fibroblast 3T3-J2 cells were kindly provided by Cary
A. Moody from the Department of Microbiology and
Immunology, University of North Carolina-Chapel Hill.
The cells were cultured in Dulbecco’s Modified Eagles
Medium (DMEM) (Life Technologies, Grand Island, NY,
USA) with 10 % heat inactivated fetal bovine serum, L-
glutamine, and penicillin-streptomycin at 37 °C in a hu-
midified atmosphere containing 5 % CO2. For use as
feeders for the vaginal epithelial cells, the fibroblasts
were grown to 70–80 % confluence and irradiated with
6000 Rads.
Primary human vaginal epithelial cell isolation and culture
Tissues routinely discarded from vaginal repair surgeries
were harvested from three otherwise healthy adult women,
with the understanding and written consent of each sub-
ject and according to ethical principles. Tissue harvesting
and experimental procedures were approved by the Insti-
tutional Review Boards of the University of Washington
and the Fred Hutchinson Cancer Research Center. Tissues
were placed in ice-cooled calcium- and magnesium-free
phosphate-buffered saline containing 100 U/ml penicillin,
100 μg/ml streptomycin and 2.5 μg/ml Fungizone (Life
Technologies), and transported to the laboratory within
1 h of removal from the donor. The deep submucosa was
removed with surgical scissors and the remaining vaginal
mucosa was cut into 5 × 5 mm pieces, which were incu-
bated at 4 °C for 18 h in 5 ml of a 25 U/ml dispase solu-
tion (BD Biosciences, Franklin Lakes, NJ, USA). The
epithelial sheets were dissected off under a stereoscope
and incubated for 10–12 min at 37 °C in 2 ml 0.05 % tryp-
sin while gently shaking. The dispersed cells were poured
through a 100 μm cell strainer into a 50 ml tube, pelleted
by centrifugation, and resuspended in F medium (3:1 [v/v]
F12 [Ham]-DMEM [Life Technologies], 5 % fetal bo-
vine serum [Gemini Bio-Products, West Sacramento,
CA, USA], 0.4 μg/ml hydrocortisone [Sigma, St. Louis,
MO, USA], 5 μg/ml insulin [Gemini Bio-Products],
8.4 ng/ml cholera toxin [EMD Millipore, Billerica, MA,
USA], 10 ng/ml epidermal growth factor [Life Technolo-
gies], 24 μg/ml adenine [Sigma], 100 U/ml penicillin,
100 μg/ml streptomycin [Life Technologies], and 2 mM
glutamine [Life Technologies]). Primary VECs were plated
into culture flasks in the presence of ~12,500/cm2 irradi-
ated (6000 Rads) 3T3-J2 feeder fibroblasts and 10 μM of
Rho kinase inhibitor Y27632 (Enzo Life Sciences, Farm-
ingdale, NY, USA) was added [32, 33]. VECs were fed
every 2–3 days and passaged when around 80 % conflu-
ence by 1 min treatment with 10 ml versene (Life Tech-
nologies) to remove the feeder cells, followed by 5 min
treatment with trypsin/EDTA (Life Technologies). Dis-
lodged VECs were washed and re-plated at ~2500 cells/
cm2 with irradiated 3T3-J2 feeder fibroblasts.
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To examine the toxicity of H. cordata water extract on
primary human VECs, cells were evaluated using the
CellTiter-Blue Cell Viability Assay (Promega, Madison,
WI, USA). VECs were treated with 25–200 μg/mlH. cor-
data water extract for 18 h. After exposure, 20 μl of
CellTiter-Blue Reagent was added to each well and the
cells were cultured for 2 h. Subsequently, fluorescence in
each well was measured with excitation/emission at 560/
590 nm. Experiments were performed in triplicate and
set up in three different donors. Viability of the cells was
expressed as percent of the untreated negative control
group.Stimulation of VECs by H. cordata water extract
Third passage VECs were treated with 25–200 μg/mlH.
cordata water extract for 6 or 18 h. Untreated cells and
cells treated with TNF-α were used as negative and posi-
tive controls, respectively. After treatment, total RNA
was isolated from the cells for subsequent PCR assays,
and culture supernatants were frozen at −80 °C for
enzyme-linked immunosorbent assay (ELISA) and Lumi-
nex assay. Experiments were set up in three different do-
nors; each experiment was performed in duplicate.Fig. 1 Cytotoxicity of VECs in the presence of H. cordata water extract.
VECs were treated with H. cordata water extract for 18 h. Cell viability
was evaluated by CellTiter-Blue cell viability assay. Results for triplicate
experiments with three different donors were normalized to untreated
cells, and mean and standard deviations (error bars) are shownRNA isolation, cDNA preparation and quantitative real-time
reverse transcription PCR
Total RNA was isolated from VECs with the RNeasy Mini
Kit and purified of contaminating DNA using RNase-free
DNase (QIAGEN, Valencia, CA, USA). 1 μg of total RNA
was reverse transcribed to complementary DNA (cDNA)
using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules,
CA, USA). Quantitative real-time PCR was conducted
using TaqMan Gene Expression Master Mix (Life Tech-
nologies) according to the manufacturer’s directions. The
primers and probes for hBD2 and SLPI were as follows:
hBD2 forward primer: 5′-TCCTGGTGAAGCTCCCA-3′;
hBD2 reverse primer: 5′-CGCCTATACCACCAAAAAC
AC-3′; hBD2 probe: 5′-/56-FAM/AGGAGATAC/ZEN/
AAGACCCTCATGGCTGA/3IABkFQ/-3′; SLPI forward
primer: 5′-CAAGCGTGACTTGAAGTGTTG-3′; SLPI re-
verse primer: 5′-GAAAGGACCTGGACCACAC-3′; SLPI
probe: 5′-/56-FAM/CCCTGTGAA/ZEN/AGCTTGATTC
CTGCCA/3IABkFQ/-3′. Primers and probes for the house-
keeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were ordered from Life Technologies. Amplifi-
cation conditions were initial denaturation at 96 °C for
15 min followed by 40 cycles of denaturation at 95 °C for
15 s and annealing/extension at 60 °C for 60 s. Amplifica-
tion of each sample was performed in duplicate and nor-
malized to the housekeeping gene. The relative expression
was calculated by Pfaffl’s method [34] and expressed as
the relative fold change of the untreated control group.ELISA and Luminex assay
Culture supernatants (collected as described above) were
evaluated for secreted hBD2 and SLPI protein by ELISA
(hBD2, Alpha Diagnostic, San Antonio, TX, USA; SLPI,
R&D Systems, Minneapolis, MN, USA). The levels of
interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, CC che-
mokine ligand (CCL) 2, CCL5, Interferon-gamma (IFN-γ),
and TNF-α were measured by Magnetic Luminex Per-
formance Assay (R&D Systems) according to the manu-
facturer’s instructions. Standard curves were generated in
every set of experiments.
Statistical analysis
Statistics were calculated with SPSS Statistics. One-way
analysis of variance (ANOVA) and/or Kruskal-Wallis test
was applied for analysis of differences between untreated
cells and cells treated with H. cordata. P-values less than
0.05 were considered to indicate significantly different
outcomes.
Results
Cytotoxicity of H. cordata water extract on primary VECs
To test for cytotoxicity, primary VECs were treated with
25–200 μg/ml of H. cordata water extract for 18 h. After
treatment, cell viability was measured by the CellTiter-
Blue assay. VEC viability after treatment with H. cordata
water extract was close to 100 % compared to untreated
control cells (Fig. 1).
Effect of H. cordata water extract on hBD2 and SLPI
Primary VECs were treated with 25–200 μg/ml of H.
cordata water extract for 18 h. By using quantitative
real-time reverse transcription PCR, the expression of
hBD2 mRNA in VECs was found to be significantly in-
creased by 2.37 fold after treatment with 100 μg/mlH.
cordata (p < 0.05) compared to untreated cells (Fig. 2a).
Fig. 2 Effect of treatment with H. cordata on hBD2 and SLPI mRNA, and protein levels. VECs were treated with H. cordata water extract for 6 or
18 h. After treatment, the expression of hBD2 and SLPI mRNA was assessed by quantitative real-time RT-PCR. The expression of hBD2 and SLPI
mRNA after treatment for 18 h (a, b) and 6 h (e, f) are shown as relative fold change compared to untreated control cells. Secretion of hBD2 and
SLPI protein in VEC culture supernatants by ELISA, and mean ± SD values of secreted protein after treatment for 18 h are shown (c, d). In all
graphs, results for duplicate experiments with three different donors for 18 h treatment and two different donors for 6 h treatment were normalized to
untreated cells, and mean and standard deviations (error bars) are shown. *, P< 0.05 compared to untreated cells
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or 200 μg/mlH. cordata was also increased, but not statis-
tically significant (Fig. 2a). The expression of SLPI mRNA
in VECs was significantly induced up to 1.53 fold after
treatment with 25, 100, or 200 μg/mlH. cordata water ex-
tract (P < 0.05; Fig. 2b). SLPI mRNA was also increased
with 50 μg/mlH. cordata but not statistically significant
(Fig. 2b).
At the level of protein secretion, hBD2 was signifi-
cantly increased from 3.1 pg/ml to 5.5 pg/ml after treat-
ment with 50 μg/mlH. cordata water extract (P < 0.05)
compared to untreated controls (Fig. 2c). The secretionof hBD2 by VECs after treatment with 25, 100 or
200 μg/mlH. cordata water extract was also increased,
but not statistically significant (Fig. 2c). In contrast, the
levels of secreted SLPI protein remained unchanged
after treatment with low doses of H. cordata, and were
slightly decreased with higher doses of the extract
(Fig. 2d).
We also measured the expression of hBD2 and SLPI
mRNA in VECs after being treated shortly with H. cordata
water extract for up to 6 h. Unlike the case of 18 h treat-
ment, 6 h of exposure with the extract had only slight effects
on hBD2 or SLPI mRNA expression in VECs (Fig. 2e, f).
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presence of H. cordata
Next, we measured the secretion of cytokines and che-
mokines in the cell culture supernatants after the cells
were treated with 50, 100 or 200 μg/ml of H. cordata
water extract for 18 h using Luminex assay. We found that
the levels of secreted IL-2 in VEC culture supernatantsFig. 3 The secretion of cytokines and chemokines by VECs. VECs were treated
and chemokines in cell culture supernatants were determined by Luminex as
after treatment are shown. Experiments were performed in duplicate with twwere significantly higher (1.2-1.4 pg/ml) than untreated
control cells (0.4 pg/ml) after treatment with 50 or 200,
but not 100, μg/mlH. cordata water extract (P < 0.05;
Fig. 3a). Similarly, the levels of secreted IL-6 were signifi-
cantly increased (from 9.4 pg/ml to 15–23 pg/ml) after the
cells were treated with 100 or 200 μg/mlH. cordata water
extract (P < 0.05; Fig. 3b). However, levels of IL-4, IL-8,with H. cordata water extract for 18 h. The levels of secreted cytokines
say. Mean and standard deviations (error bars) of cytokine concentrations
o different donors. *, P < 0.05 compared to untreated control group
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ences in the presence of the extract compared to un-
treated control cells (Fig. 3c, d, e, f ). In contrast, the level
of CCL5 was decreased from a basal level of 172 pg/ml to
88–114 pg/ml at the concentrations tested (P < 0.05;
Fig. 3g). The levels of secreted IL-1β, IL-10, and IFN-γ
proteins were also measured, however, they were at un-
detectable levels.
Discussion
This study demonstrated that vaginal innate immune
mediators are modulated by H. cordata water extract at
the concentration up to 200 μg/ml without cytotoxicity.
Increased hBD2 and SLPI gene expression, as well as
hBD2, IL-2 and IL-6 protein secretion were found after
the cells were treated with the extract for 18 h. In con-
trast, decreased CCL5 protein secretion by primary hu-
man VECs was noted.
Epithelial cells lining vagina provide the first line of
defense against pathogenic microorganisms in the female
genital tract. The cells play an active role both in phys-
ical and chemical barriers, including the production of
antimicrobial peptides [1, 2, 6]. Our findings on the ef-
fects of H. cordata on modulating the innate immune
mediators produced by VECs are consistent with that of
a previous study by Luo et al. (2008), which reported
that H. cordata can induce the expression of hBD2 in
pulmonary epithelial cells [35].
Several studies revealed that hBD2 is an important
antimicrobial peptide, because it is expressed in epithe-
lial cells in response to microbial compounds, microbes
and cytokines [18–21] and can inhibit several pathogenic
bacteria [9], and Candida species [8]. Interestingly, it
can inhibit HIV-1 transmission by directly inactivating
HIV-1 virions, down-modulating HIV-1 co-receptor
CXCR4, and inhibiting HIV replication [7, 15]. Thus, the
induced expression of hBD2 by H. cordata water extract
may be a useful feature of an anti-HIV microbicide or
an antimicrobial agent for sexually transmitted diseases
of the female reproductive tract.
Although the present study demonstrated that hBD2
was induced by the extract, it is not known whether the
induction of antimicrobial peptides by the extract is suf-
ficient to prevent or inhibit infection at the vaginal mu-
cosa. Therefore, further study should be performed using
functional assays to examine if the changes in antimicro-
bial peptide levels induced by the extract could prevent
the proliferation of pathogens such as HIV and C. albi-
cans. In addition, topical effects of the extract should be
further explored in vivo.
SLPI is constitutively produced by several cell types in-
cluding VECs [4, 36] and can also be induced by inflam-
matory mediators [22]. We found that the water extract
of H. cordata increased the expression of SLPI mRNAby VECs after treatment for 18 h. However, the secretion
of SLPI protein was not found to be increased. This dis-
crepancy may be due to a stimulation time that was not
suitable to detect SLPI protein secretion. It may also due
to degradation of SLPI in VEC culture media as a recent
study reported that the secreted protein level of SLPI
did not reflect mRNA expression, suggesting rapid deg-
radation of SLPI protein in the culture supernatant [37].
Further studies should be performed to determine the
expression of SLPI in VECs after longer incubation of H.
cordata to measure the level of SLPI in the late time
point and to investigate the intracellular level of SLPI
protein in VECs by a western blot.
Mucosal epithelial cells secrete cytokines and chemo-
kines in response to microorganisms and other cytokines
[5, 12]. Here, we demonstrated that the water extract of
H. cordata increased the secretion of cytokines IL-2 and
IL-6 by VECs. Although IL-2 is mainly produced by T
lymphocytes, it can also be secreted at low levels by epi-
thelial cells [38]. IL-6 is produced by different epithelia,
including VECs [5, 12]. These cytokines play important
roles in the host immune responses in both innate and
adaptive immunity. IL-2 mediates the proliferation and
activation of T cells and also activates natural killer cells
and B-cells [13]. A previous study reported that highly
active antiretroviral therapy combined with IL-2 can
provide beneficial effects in the treatment of early HIV-1
infection [39]. IL-6 is a multifunctional cytokine with
both pro-inflammatory and immunoregulatory functions
[12, 13, 40]. It mediates the differentiation of B-cells and
enhances immunoglobulin secretion [12, 13]. Moreover,
IL-6 shows anti-inflammatory activity by inhibiting IL-1
and TNF [13]. On the other hand, IL-6 also has pro-
inflammatory activity which may lead to undesirable ef-
fects such as inflammation. Further studies should be
performed to elucidate if H. cordata extract might im-
pose any adversary effects on the vaginal immunity. Of
interest, previous studies demonstrated that IL-6 can in-
hibit HIV-1 replication in macrophages and plays a pro-
tective role in host immune responses against infections
with various pathogens such as Escherichia coli, Chla-
mydia trachomatis, and C. albicans [41–44]. Thus, fur-
ther studies should be carried out to explore whether
cytokine alterations in VECs caused by H. cordata ex-
tract have functional effects, and whether the shift of
cytokine profile in the culture supernatants can modify
lymphocyte function and proliferation.
In addition to induction of IL-2 and IL-6, the water
extract of H. cordata reduced the levels of CCL5 in the
supernatants while the levels of IL-4 and TNF-α did not
change. CCL5/RANTES has been identified as the HIV-
suppressive factor [45], however, the decreased level of
CCL5 after treatment with H. cordata may interrupt the
effect of H. cordata in vaginal innate immunity regarding
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1 inhibition in the target cells should be investigated in
the future.
A recent study reported that the polysaccharide HCP-2
isolated from H. cordata water extract induced the secre-
tion of IL-1β, TNF-α, and CCL5/RANTES by human per-
ipheral blood mononuclear cells [46]. The production of
IL-1β, IL-6, and TNF-α by mouse peritoneal macrophages
was also enhanced by H. cordata [47]. Moreover, the pro-
duction of IL-2 and IL-10 by mouse splenic lymphocytes
was increased after treatment with H. cordata, whereas the
level of IFN-γ decreased and the level of IL-4 remained un-
changed [48]. These divergent results are likely due to vary-
ing methodological conditions, for example, tissue model,
cell type, time of treatment, and dose of the extract.
The crude extract of H. cordata used in this study con-
tains various substances. It is therefore unclear whether
the observed modulation of immune mediators was
caused by a single component or several. Thus, purifi-
cation of different components of the crude extract of H.
cordata should be done in the future. In addition, further
studies should be performed to determine whether combi-
nations of those active ingredients would be useful in the
modulation of different immune mediators.
It has been shown that H. cordata possesses antimicro-
bial activities against several pathogenic microbes including
Staphylococcus aureus and E. coli [23], however, the effects
of H. cordata on the vaginal normal flora such as Lactoba-
cilli are still not known and should also be determined.Conclusions
Our study indicates that H. cordata water extract induces
the expression of antimicrobial peptides hBD2 and SLPI as
well as the secretion of cytokines IL-2 and IL-6 by VECs
and reduces the secretion of CCL5. These immune media-
tors have a significant role in innate and adaptive immune
responses. These findings suggest that H. cordata extracts
may be a useful immunomodulatory addition to vaginal
microbicides and should be further investigated.
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